Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. حسب Tosi M. Mwakyandile (16408705)

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. حسب Tosi M. Mwakyandile (16408705)

Effect of DM, and/or <i>M. charantia</i> on the immuno-expressional level of GFAP protein in maternal cerebellar tissue of different groups. حسب Amoura M. Abou-El-Naga (21001524)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. حسب Michele Angelo Colombo (22446342)

Study group background characteristics. حسب Zicheng Hu (3825313)

"…The dashed horizontal lines in <b>Fig 1K</b>–<b>1O</b> indicate the mean +2 SD of the uninfected, seronegative (<b><i>HIV-</i></b>) control group in the measured variable as a rough estimate of their upper normal limit and as a visual guide to compare groups; this convention is also used in the Olink CSF protein measurement figures showing the group profiles in subsequent figures. …"

Tuning curve sharpening and familiarity suppression. حسب Weifan Wang (4669081)

Image 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.tiff حسب Stig P. Cramer (20908724)

Data Sheet 1_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf حسب Stig P. Cramer (20908724)

Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx حسب Jae-Sung Lim (532986)

Data Sheet 2_Insights from DCE-MRI: blood–brain barrier permeability in the context of MS relapses and methylprednisolone treatment.pdf حسب Stig P. Cramer (20908724)